Evidence map›Paper›PMID 41858780›Full record

ArticleFrontiers in cell and developmental biology2026

Remics: a redescription-based framework for multi-omics analysis.

Aritra Bose, Daniel E Platt, Kahn Rhrissorrakrai, Myson Burch, Aldo Guzmán-Sáenz, Niina Haiminen, Laxmi Parida

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aritra BoseIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.
Daniel E PlattIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.
Kahn RhrissorrakraiIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.
Myson BurchIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.
Aldo Guzmán-SáenzIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.
Niina HaiminenDAIN Studios, Helsinki, Finland.
Laxmi ParidaIBM T.J. Watson Research Center, Yorktown Heights, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex diseases such as cancer are characterized by their intricate etiology, arising from several molecular mechanisms that span multiple omic layers. To obtain insights on disease subtypes, associated biomarkers, and improve prognostic modeling, it is essential to integrate and interpret multi-omics data in a biologically meaningful way. We introduce Remics, a redescription-based framework for multi-omics integration inspired by higher-order statistical representations. Remics leverages higher-order cumulants to identify redescriptions, which are sets of multi-omics features that jointly capture equivalent biological variation across modalities. These feature groups are further analyzed through network representations, multi-omics risk scoring, and biomarker discovery to reveal molecular interactions underlying disease mechanisms. We applied Remics on simulated data as well as multi-omics data of six different cancer types from The Cancer Genome Atlas. We demonstrate that redescription-based integration uncovers functionally coherent cross-omics feature associations and compare them with state-of-the-art approaches. Our results highlight the potential of higher-order multi-omics statistical analysis to advance precision medicine through improved interpretability and discovery of novel molecular relationships.

Indexed as

biomarker discoverydata miningdisease predictiongenetic epidemiologymulti-omicsnetworksstatistics

Identifiers

PMID41858780
PMCPMC12996823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.